Compare Sunrun Inc (RUN) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sunrun Inc vs Twist Bioscience Corp — how do they compare? Sunrun Inc trades at $8.79 (market cap $2.12B), while Twist Bioscience Corp trades at $125.52 (market cap $8.26B). The key difference: Twist Bioscience Corp is far larger — about 3.9× Sunrun Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals.
| RUN | TWST | |
|---|---|---|
Market Cap | $2.12B | $8.26B |
Sector | Technology | Health |
52-Week High | $21.41 | $153.10 |
52-Week Low | $8.37 | $24.16 |
Enterprise Value | $16.64B | $8.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sunrun (RUN) trades at $9.22, up 3.71% in the last session, with a bearish technical outlook despite recent earnings beats. The stock shows low valuation multiples (P/E of 5.99, P/S of 0.69) and strong analyst support (62% buy ratings), but faces headwinds from negative operating cash flow and high debt. Recent news highlights guidance cuts and solar tariff impacts, while storage growth offers a potential catalyst.
The outlook is mixed: attractive valuations and storage partnerships support upside to the $14.70 consensus target, but profitability pressures and cash flow challenges pose risks. Investors should weigh low multiples against execution risks in a competitive solar market.
Twist Bioscience (TWST) trades at $128.06, up 2.68% with a bearish technical signal despite recent AI-driven momentum. The company shows strong revenue growth (2025: $377M, 2026: $432M projected) but continues to report significant losses with negative net margins. Recent news highlights AI partnerships and a $300M stock offering, while analyst consensus remains predominantly bullish with 78.6% buy ratings.
TWST presents a high-risk growth opportunity with accelerating revenue but persistent profitability challenges. The stock's valuation appears stretched at P/S of 18.09, requiring successful execution on AI initiatives and path to EBITDA breakeven. Key risks include cash burn, competitive pressures, and dependence on emerging AI-driven drug discovery markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
